Integrating oral PrEP delivery among African women in a large HIV endpoint‐driven clinical trial

May 20, 2020

Global guidelines emphasize the ethical obligation of investigators to help participants in HIV‐endpoint trials reduce HIV risk by offering an optimal HIV prevention package. Oral pre‐exposure prophylaxis (PrEP) has increasingly become part of state‐of‐the‐art HIV prevention. Here the study describes the process of integrating oral PrEP delivery into the HIV prevention package of the Evidence for Contraceptive Options and HIV Outcomes (ECHO) Trial. Journal of the International AIDS Society


Other news

Cookies help us deliver our services. By using our services, you agree to our use of cookies. What are cookies?